← Back to all trials
Recruiting
NCT05633277
Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections
Conditions: Venous Reflux, Venous Insufficiency, Venous Ulcer, Venous Disease
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 30
Sponsor: ProMedica Health System
Location: United States
Summary
Randomized Controlled Trial to determine if the outcomes of sclerotherapy of the ulcer bed alone differ from a combination of ablation and sclerotherapy injections.
Eligibility Criteria
Inclusion Criteria:Patients who have saphenous vein reflux and a single venous ulcer of any sizeExclusion Criteria:Patients with multiple venous ulcers
Source: ClinicalTrials.gov (NCT05633277). StuddyBuddy aggregates publicly available trial information.
